Breaking News

Hetero Wins Approval for Generic Sofosbuvir in India

Will launch Sofovir in India this month

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Hetero, based in Hyderabad, India, has received approval for generic Sofosbuvir Tablets, 400 mg (Gilead’s SOVALDI), from the Drug Controller General of India. Hetero has a non-exclusive license agreement with Gilead Sciences, Ireland to manufacture and sell generic versions of its chronic hepatitis C medicines in 91 developing countries.   Hetero will launch Sofosbuvir under its brand Sofovir in India this month with other countries to follow. Hetero has also partnered with other licensee holder...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters